Loading
OT
of the Board Stock: price and insider trades · Denmark
of the Board: what insiders have been doing
of the Board has a thin disclosure history in our data (latest filing: 11 August 2023). New filings will appear here as soon as they are published. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€46,425
1 ops. · all time
Analyst consensus: bullish or bearish?
Analysts rate of the Board Hold (neutral), based on 24 analysts. Average price target: DKK 317.20.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,022 of 24,148 companies
75.3
score / 100
Value62
Quality89
FCF yld2.0%
Earn yld7.2%
EV/EBITDA9.9x
ROE71%
Gross mgn81%
Net mgn33%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
DKK 320.30
Analyst consensus
24 analystsHold
DKK 200.00Target DKK 317.20(-1%)DKK 453.00
Income statement
RevenueDKK 309.1B
Gross profitDKK 250.3B81% margin
EBITDADKK 156.7B51% margin
Net incomeDKK 102.4B37.2% margin
Valuation
PER (trailing)11.7x
PER (forward)14.9x
P/Book7.0x
Beta0.36
Balance sheet & cash
Market capDKK 1.4T
Total debtDKK 131B
Free Cash FlowDKK 29B
Debt / Equity72%
Profitability & ownership
ROE71.4%
ROA19.2%
% insiders5.3%
% institutions33.6%
Last declaration on 11 August 2023
Declarations1 total
276 shares@ DKK 1,253.480.0000% mcap100.0% of flowShareNew York Stock ExchangeISIN DK0060534915DK:1242120
1 of 1 declaration
About of the Board
of the Board is a company operating in the healthcare and pharmaceutical sector, listed on the XCSE.
